• Nootropic 99% Armodafinil powder CAS 112111-43-0 Armodafinil

Nootropic 99% Armodafinil powder CAS 112111-43-0 Armodafinil

stars, based on ( 0 )reviews
$1.00 kilogram
0items available

We are factory from China.We make Nootropics raw material.

We can also make capsules, tablets, and liquid drops. Customers brand is accpetable.

Our email is sales@sarms4muscle.com

Armodafinil as opposed to the racemic formulation, which contains a 50/50 mix of both the (S) and (R) enantiomers, armodafinil consists of just the (R)-enantiomer, which is a synthetic nootropic and eugeroic (i.e. wakefulness-promoting agent) of the benzhydryl chemical class.

Name: Armodafinil

CAS: 112111-43-0

M.W.: 273.35

Formula: C15H15NO2S

Appearance:White powder

Specification:99%

Armodafinil was approved by the U.S. Food and Drug Administration (FDA) in June 2007 for the treatment of obstructive sleep apnea, shift work sleep disorder, and narcolepsy.

Armodafinil can produce rewarding psychoactive and euphoric effects such as alterations in mood, perception, thinking, and feelings typically observed with other central nervous system (CNS) stimulants in humans.

What is Armodafinil?

Armodafinil as opposed to the racemic formulation, which contains a 50/50 mix of both the (S) and (R) enantiomers, armodafinil consists of just the (R)-enantiomer, which is a synthetic nootropic and eugeroic (i.e. wakefulness-promoting agent) of the benzhydryl chemical class.

Uses of Armodafinil:

Armodafinil was approved by the U.S. Food and Drug Administration (FDA) in June 2007 for the treatment of obstructive sleep apnea, shift work sleep disorder, and narcolepsy.

Armodafinil can produce rewarding psychoactive and euphoric effects such as alterations in mood, perception, thinking, and feelings typically observed with other central nervous system (CNS) stimulants

Armodafinil as opposed to the racemic formulation, which contains a 50/50 mix of both the (S) and (R) enantiomers, armodafinil consists of just the (R)-enantiomer, which is a synthetic nootropic and eugeroic (i.e. wakefulness-promoting agent) of the benzhydryl chemical class.

Uses of Armodafinil:

Armodafinil was approved by the U.S. Food and Drug Administration (FDA) in June 2007 for the treatment of obstructive sleep apnea, shift work sleep disorder, and narcolepsy.

Armodafinil can produce rewarding psychoactive and euphoric effects such as alterations in mood, perception, thinking, and feelings typically observed with other central nervous system (CNS) stimulants in humans.

Tags: nootropic 99% armodafinil powder

Recent Reviews
+